SCHEMBL7522183

SCHEMBL7522183

O=C(O)C(=O)Nc1sc2c(c1C(=O)O)CC(CNC(=O)c1ccc(-c3ccccc3)cc1)NC2

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 15/20 0.46
PTPN2 P17706 8/20 0.46
PTPRC P08575 2/20 0.43
RAB9A P51151 2/20 0.41
LMNA P02545 1/20 0.41
POLB P06746 1/20 0.41
MAPT P10636 1/20 0.41
HPGD P15428 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
ESR2 Q92731 1/20 0.41
CTDSP1 Q9GZU7 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
MEN1 O00255 1/20 0.40
NPC1 O15118 1/20 0.40
ALDH1A1 P00352 1/20 0.40
KMT2A Q03164 1/20 0.40
PTPRB P23467 1/20 0.39
PTPRE P23469 1/20 0.39
PTPN6 P29350 1/20 0.39
RAB7A P51149 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7519532 0.94 PTPN1 (0.47) PTPN1PTPN2PTPRCRAB9ALMNA
SCHEMBL7520464 0.91 PTPN1 (0.44) PTPN1PTPN2PTPRCRAB9ALMNA
SCHEMBL7517024 0.91 RAB9A (0.44) PTPN1PTPN2PTPRCRAB9ALMNA
SCHEMBL7519819 0.91 RAB9A (0.44) PTPN1PTPN2PTPRCRAB9ALMNA
SCHEMBL7513085 0.88 PTPN1 (0.47) PTPN1PTPN2PTPRCRAB9ANPC1
SCHEMBL7518656 0.86 PTPN1 (0.51) PTPN1PTPN2PTPRCPTPRBPTPRE
SCHEMBL7520917 0.85 PTPN1 (0.42) PTPN1PTPN2PTPRCRAB9ALMNA
SCHEMBL7515936 0.85 PTPN1 (0.43) PTPN1PTPN2PTPRCMEN1KMT2A
SCHEMBL7525515 0.84 RAB9A (0.45) PTPN1PTPN2PTPRCRAB9APOLB
SCHEMBL7520327 0.82 PTPN1 (0.43) PTPN1PTPN2PTPRCRAB9AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020099073-A1 Modulators of protein tyrosine phosphatases (PTPases) NOVO NORDISK A/S (DK) 2002-07-25 US claimed
WO-2002004458-A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPASES) NOVO NORDISK A/S (DK) 2002-01-17 WO claimed
US-20020099073-A1 Modulators of protein tyrosine phosphatases (PTPases) NOVO NORDISK A/S (DK) 2002-07-25 US disclosed
WO-2002004458-A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPASES) NOVO NORDISK A/S (DK) 2002-01-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020099073-A1 Modulators of protein tyrosine phosphatases (PTPases) PTPN1, PTPRO, PTPRS PTPN1 1/4885PTPN2 14/4885PTPRC 6/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.